Decision Diagnostics Corp. With a focus on providing affordable and FDA/CE compliant testing solutions, Decision Diagnostics Corp, through its subsidiary PharmaTech Solutions, Inc., develops innovative products for patients and healthcare providers. Their diverse brand portfolio includes GenUltimate!®, GenChoice!®, GenPrecis!®, and GenUltimate!® TBG, which are proprietary replacements for popular glucose monitoring systems like LifeScan OneTouch® Ultra®, Abbott Freestyle Lite®, Lifescan OneTouch® Select Plus, and LifeScan OneTouch® Select.

These products are globally available and provide accurate and reliable glucose monitoring. Decision Diagnostics Corp. With a commitment to excellence, the company prioritizes investor information and regularly updates the investment community and followers on topics like litigations, court rulings, business implications, partnerships, and pipeline products.

For inquiries, contact Decision Diagnostics Corp